TP53 and gastrointestinal stromal tumor: Unlike tyrosine kinase inhibitors (e.g., imatinib, sunitinib, regorafenib, and ripretinib), which primarily exert cytostatic effects [10], our results showed that HDM201 has the potential to induce apoptosis specifically in p53 WT GIST cells.